Alaunos Therapeutics (TCRT) SEC Filings & 10K Form

$2.45 -0.18 (-6.84%)

Closing price 04/28/2025 04:00 PM Eastern

Extended Trading

$2.42 -0.03 (-1.02%)

As of 04/28/2025 05:43 PM Eastern

Compare

Recent Alaunos Therapeutics SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/15/2025 7:26 PM	Alaunos Therapeutics, Inc. (Issuer) Alaunos Therapeutics, Inc. (Issuer) Alaunos Therapeutics (Issuer) Vieser Jaime (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
04/14/2025 8:15 AM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/13/2025 3:15 PM	Alaunos Therapeutics, Inc. (Subject) Alaunos Therapeutics, Inc. (Subject) Alaunos Therapeutics (Subject) MSD Partners, L.P. (Filed by)	Form SCHEDULE 13G/A
12/31/2024 4:10 PM	Alaunos Therapeutics, Inc. (Subject) Alaunos Therapeutics, Inc. (Subject) Alaunos Therapeutics (Subject) Vieser Jaime (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
11/14/2024 8:30 AM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
10/10/2024 7:30 AM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/16/2024 3:35 PM	Alaunos Therapeutics, Inc. (Issuer) Alaunos Therapeutics, Inc. (Issuer) Alaunos Therapeutics (Issuer) Groenewald Ferdinand (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/16/2024 5:58 PM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 8-K/A
07/16/2024 5:58 PM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 8-K/A
07/16/2024 8:00 AM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/16/2024 8:02 AM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/21/2024 4:01 PM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/15/2024 7:57 AM	Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics, Inc. (Filer) Alaunos Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies

SEC Filings Tools

This page (NASDAQ:TCRT) was last updated on 4/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alaunos Therapeutics (TCRT) SEC Filings & 10K Form

Recent Alaunos Therapeutics SEC Filings

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alaunos Therapeutics (TCRT) SEC Filings & 10K Form

Recent Alaunos Therapeutics SEC Filings

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools